Dong-A Pharmaceutical Renews Packaging for Dry Skin Treatment 'Ichinon Cream'

Donga Pharmaceutical's skin dryness treatment 'Ichinon Cream' package renewal product. Photo by Donga Pharmaceutical

Dong-A Pharmaceutical announced on the 3rd that it has renewed the packaging of Ichinon Cream, a treatment for xerosis (dry skin).

The newly redesigned package features a design that emphasizes the product's key characteristics to enhance consumer understanding. The front of the package includes the phrase "Treatment for itching caused by xerosis" to highlight the main indication of the product, and it also states that it is steroid-free, a major feature.

On the side, the four complex ingredients of Ichinon Cream?▲Heparinoid ▲Diphenhydramine ▲Tocopherol Acetate ▲Allantoin?are visualized to intuitively convey the characteristics of each ingredient to consumers.

Launched in 2019, Ichinon Cream contains moisturizing-effective Heparinoid, Tocopherol Acetate, Diphenhydramine which relieves itching, and Allantoin. In particular, the excellent moisturizing power of Heparinoid helps maintain moisture in dry skin.

As a cream, it has minimal greasiness and is gently absorbed into the skin. Additionally, since it does not contain steroid ingredients, consumers can use it without concern.

Ichinon Cream is an over-the-counter drug available at pharmacies. The usage method is to apply an appropriate amount several times a day to the affected area. It can be used by children aged 6 and older.

A Dong-A Pharmaceutical representative said, "This package renewal focuses on intuitively showing the product's characteristics to increase understanding of the product," and added, "We hope that Ichinon Cream will help maintain moisture in skin that becomes drier and more fragile due to temperature fluctuations during the changing seasons."

This content was produced with the assistance of AI translation services.